IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)

FEBS Letters

Volumn 585, Issue 1, 2011, Pages 159-166

  Henkels, Karen M ^a   Frondorf, Kathleen ^a   Gonzalez Mejia, M Elba ^b   Doseff, Andrea L ^b   Gomez Cambronero, Julian ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Flavonoid; Inflammation; Janus kinase 3; Kinase; Neutrophil; Proleukemic cell

Indexed keywords

APIGENIN; HISTONE H2B; INTERLEUKIN 8; JANUS KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; S6 KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRAIN HL 60; CHEMOKINESIS; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TIME;

APIGENIN; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; INTERLEUKIN-8; JANUS KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR STRUCTURE; NEUTROPHILS; PHOSPHORYLATION; PROTEIN KINASE C; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA INTERFERENCE; TIME FACTORS; TOR SERINE-THREONINE KINASES;

EID: 78650856477     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.11.031     Document Type: Article

References (59)

1. S.M. Russell Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID Science 266 1994 1042 1045
2. S.M. Russell Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development Science 270 1995 797 800
3. S.G. Rane, and E.P. Reddy JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells Oncogene 9 1994 2415 2423
4. T. Musso, J.A. Johnston, D. Linnekin, L. Varesio, T.K. Rowe, J.J. O'Shea, and D.W. McVicar Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7 J. Exp. Med. 181 1995 1425 1431
5. D.C. Thomis, C.B. Gurniak, E. Tivol, A.H. Sharpe, and L.J. Berg Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3 Science 270 1995 794 797
6. T. Nosaka Defective lymphoid development in mice lacking Jak3 Science 270 1995 800 802
7. G. Soldevila, I. Licona, A. Salgado, M. Ramirez, R. Chavez, and E. Garcia-Zepeda Impaired chemokine-induced migration during T-cell development in the absence of Jak 3 Immunology 112 2004 191 200
8. E.A. Sudbeck, X.P. Liu, R.K. Narla, S. Mahajan, S. Ghosh, C. Mao, and F.M. Uckun Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents Clin. Cancer Res. 5 1999 1569 1582 (Pubitemid 29282966)
9. S.J. Baker, S.G. Rane, and E.P. Reddy Hematopoietic cytokine receptor signaling Oncogene 26 2007 6724 6737
10. P.S. Changelian Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor Science 302 2003 875 878
11. F. Behbod Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts J. Immunol. 166 2001 3724 3732
12. J.R. Cortes, G.M. Perez, M.D. Rivas, and J. Zamorano Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3 J. Immunol. 179 2007 3881 3887
13. P. Proost, A. Wuyts, and J. van Damme The role of chemokines in inflammation Int. J. Clin. Lab. Res. 26 1996 211 223
14. R. Gillitzer, and M. Goebeler Chemokines in cutaneous wound healing J. Leukoc. Biol. 69 2001 513 521
15. R. Benelli Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation FASEB J. 16 2002 267 269
16. K.M. Beeh, J. Beier, O. Kornmann, and R. Buhl Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis Sarcoidosis Vasc. Diffuse Lung Dis. 20 2003 138 143
17. J.M. Wang Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells Arterioscler. Thromb. 11 1991 1166 1174
18. D.J. Waugh, and C. Wilson The interleukin-8 pathway in cancer Clin. Cancer Res. 14 2008 6735 6741
19. S. Sozzani, D.E. Agwu, M.D. Ellenburg, M. Locati, M. Rieppi, A. Rojas, A. Mantovani, and L.C. McPhail Activation of phospholipase D by interleukin-8 in human neutrophils Blood 84 1994 3895 3901
20. A. Walz, R. Burgener, B. Car, M. Baggiolini, S.L. Kunkel, and R.M. Strieter Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 J. Exp. Med. 174 1991 1355 1362
21. C. Rudack, S. Jorg, and F. Sachse Biologically active neutrophil chemokine pattern in tonsillitis Clin. Exp. Immunol. 135 2004 511 518
22. P.M. Murphy The molecular biology of leukocyte chemoattractant receptors Annu. Rev. Immunol. 12 1994 593 633
23. O. Nufer, M. Corbett, and A. Walz Amino-terminal processing of chemokine ENA-78 regulates biological activity Biochemistry 38 1999 636 642
24. N. Lehman, M. Di Fulvio, N. McCray, I. Campos, F. Tabatabaian, and J. Gomez-Cambronero Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2 Blood 108 2006 3564 3572
25. T. Yoshikawa, G. Dent, J. Ward, G. Angco, G. Nong, N. Nomura, K. Hirata, and R. Djukanovic Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 175 2007 473 479 (Pubitemid 46354251)
26. J.A. Lehman, C.C. Paul, M.A. Baumann, and J. Gomez-Cambronero MAP kinase upregulation after hematopoietic differentiation: role of chemotaxis Am. J. Physiol. Cell Physiol. 280 2001 C183 C191
27. M.A. Vargo, O.H. Voss, F. Poustka, A.J. Cardounel, E. Grotewold, and A.I. Doseff Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells Biochem. Pharmacol. 72 2006 681 692
28. J. Li, H. Nara, M. Rahman, F.M. Juliana, A. Araki, and H. Asao Impaired IL-7 signaling may explain a case of atypical JAK3-SCID Cytokine 49 2010 221 228
29. J. Hempel, H. Pforte, B. Raab, W. Engst, H. Bohm, and G. Jacobasch Flavonols and flavones of parsley cell suspension culture change the antioxidative capacity of plasma in rats Nahrung 43 1999 201 204
30. W.B. Phippen, and J.E. Simon Anthocyanin inheritance and instability in purple basil (Ocimum basilicum L.) J. Hered. 91 2000 289 296
31. M. Wang, J.E. Simon, I.F. Aviles, K. He, Q.Y. Zheng, and Y. Tadmor Analysis of antioxidative phenolic compounds in artichoke (Cynara scolymus L.) J. Agric. Food Chem. 51 2003 601 608
32. K.H. Miean, and S. Mohamed Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants J. Agric. Food Chem. 49 2001 3106 3112
33. J.Y. Kim, E.Y. Kwon, Y.S. Lee, W.B. Kim, and J.Y. Ro Eupatilin blocks mediator release via tyrosine kinase inhibition in activated guinea pig lung mast cells J. Toxicol. Environ. Health A 68 2005 2063 2080
34. B.H. Ahn, G. Min, Y.S. Bae, and D.S. Min Phospholipase D is activated and phosphorylated by casein kinase-II in human U87 astroglioma cells Exp. Mol. Med. 38 2006 55 62
35. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
36. G. Agullo, L. Gamet-Payrastre, S. Manenti, C. Viala, C. Remesy, H. Chap, and B. Payrastre Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition Biochem. Pharmacol. 53 1997 1649 1657
37. Y.T. Huang, M.L. Kuo, J.Y. Liu, S.Y. Huang, and J.K. Lin Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin Eur. J. Cancer 32A 1996 146 151
38. R.L. Geahlen, N.M. Koonchanok, J.L. McLaughlin, and D.E. Pratt Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds J. Nat. Prod. 52 1989 982 986
39. S. Yamashita, T. Yamashita, K. Yamada, and H. Tachibana Flavones suppress type I IL-4 receptor signaling by down-regulating the expression of common gamma chain FEBS Lett. 584 2010 775 779
40. J. Fang, C. Xia, Z. Cao, J.Z. Zheng, E. Reed, and B.H. Jiang Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways FASEB J. 19 2005 342 353
41. B. Plaumann, M. Fritsche, H. Rimpler, G. Brandner, and R.D. Hess Flavonoids activate wild-type p53 Oncogene 13 1996 1605 1614
42. J.J. Reiners Jr., R. Clift, and P. Mathieu Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor Carcinogenesis 20 1999 1561 1566
43. W. Wang, L. Heideman, C.S. Chung, J.C. Pelling, K.J. Koehler, and D.F. Birt Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines Mol. Carcinogen. 28 2000 102 110
44. F. Sato, Y. Matsukawa, K. Matsumoto, H. Nishino, and T. Sakai Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells Biochem. Biophys. Res. Commun. 204 1994 578 584
45. S. Malinge Activating mutations in human acute megakaryoblastic leukemia Blood 112 2008 4220 4226
46. C. Haan, S. Kreis, C. Margue, and I. Behrmann Jaks and cytokine receptors - an intimate relationship Biochem. Pharmacol. 72 2006 1538 1546
47. W.J. Leonard, and J.J. O'Shea Jaks and STATs: biological implications Annu. Rev. Immunol. 16 1998 293 322
48. S.J. Wilson, B.A. Leone, D. Anderson, A. Manning, and S.T. Holgate Immunohistochemical analysis of the activation of NF-kappaB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation J. Pathol. 189 1999 265 272
49. I. Striz, T. Mio, Y. Adachi, S. Carnevali, D.J. Romberger, and S.I. Rennard Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells Int. J. Immunopharmacol. 22 2000 573 585
50. H. Vliagoftis, A.D. Befus, M.D. Hollenberg, and R. Moqbel Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2 J. Allergy Clin. Immunol. 107 2001 679 685
51. R. Malaviya, C. Navara, and F.M. Uckun Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria Immunity 15 2001 313 321
52. B.R. Avalos, J.M. Parker, D.A. Ware, M.G. Hunter, K.A. Sibert, and B.J. Druker Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils Exp. Hematol. 25 1997 160 168
53. C. Nicholas Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation J. Immunol. 179 2007 7121 7127
54. X.W. Hu, D. Meng, and J. Fang Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase Carcinogenesis 29 2008 2369 2376
55. F. Lindenmeyer, H. Li, S. Menashi, C. Soria, and H. Lu Apigenin acts on the tumor cell invasion process and regulates protease production Nutr. Cancer 39 2001 139 147
56. W.J. Lee, W.K. Chen, C.J. Wang, W.L. Lin, and T.H. Tseng Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 226 2008 178 191
57. M. Piantelli, C. Rossi, M. Iezzi, R. La Sorda, S. Iacobelli, S. Alberti, and P.G. Natali Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions J. Cell. Physiol. 207 2006 23 29
58. J. Czyz, Z. Madeja, U. Irmer, W. Korohoda, and D.F. Hulser Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro Int. J. Cancer 114 2005 12 18
59. C.A. Franzen The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism Cancer Prev. Res. (Philadelphia, PA) 2 2009 830 841